デフォルト表紙
市場調査レポート
商品コード
1186609

乳房再建市場:現状分析・予測 (2022年~2028年)

Breast Reconstruction Market: Current Analysis and Forecast (2022-2028)

出版日: | 発行: UnivDatos Market Insights Pvt Ltd | ページ情報: 英文 163 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.98円
乳房再建市場:現状分析・予測 (2022年~2028年)
出版日: 2022年12月01日
発行: UnivDatos Market Insights Pvt Ltd
ページ情報: 英文 163 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

乳房再建の市場規模は2022年から2028年にかけて約5.1%のCAGRで成長すると予測されています。

これは主に、乳房移植の増加、手術技術のアベイラビリティと進歩、乳房のサイズや形状改善へのニーズ、乳癌に対する意識・懸念の高まりなどに起因しています。また、世界の乳癌の増加に伴い、多くの女性が乳房切除後に元の形を取り戻すために再建術を選択しています。さらに、R&D活動の高まりなども市場にも大きく貢献すると予想されています。

当レポートでは、世界の乳房再建の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、法規制環境、需給動向、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法・前提因子

第3章 市場概要

第4章 エグゼクティブサマリー

第5章 COVID-19:乳房再建市場への影響

第6章 乳房再建市場:収益の推移・予測

第7章 市場洞察:製品タイプ別

  • 乳房インプラント
  • 組織拡張器
  • 無細胞皮膚マトリックス(ADM)

第8章 市場洞察:処置別

  • 即時手術
  • 遅延手術
  • リビジョン手術

第9章 市場洞察:配置別

  • デュアルプレーン挿入
  • 腺下挿入
  • 筋肉下挿入

第10章 市場洞察:エンドユーザー別

  • 病院
  • 外来手術センター
  • 美容クリニック

第11章 市場洞察:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第12章 乳房再建市場:市場力学

  • 市場促進要因
  • 市場課題
  • 影響分析

第13章 乳房再建市場:市場機会

第14章 乳房再建市場:市場動向

第15章 政策と規制の枠組み

第16章 需要サイド・供給サイドの分析

  • 需要サイド分析
  • 供給サイド分析

第17章 バリューチェーン分析

第18章 競合シナリオ

第19章 企業プロファイル

  • Mentor Worldwide LLC
  • Allergan Inc.
  • Johnson & Johnson
  • SientraInc
  • GC Aesthetics
  • Ideal Implant Incorporated
  • POLYTECH Health & Aesthetics GmbH
  • CEREPLAS
  • AbbVie Inc.
  • Establishment Labs S.A.

第20章 免責事項

目次
Product Code: UMME211420

The breast reconstruction market is expected to register a CAGR of around ~5.1% over the period of 2022-2028. This is mainly due to its increasing number of breast implantation, availability and advancements in surgical techniques, the urge to ameliorate breast size & shape, and raising awareness and concerns about breast cancer. Also, with the increasing prevalence of breast cancer worldwide, many women are opting for reconstruction procedures to regain the original shape of their breasts after the mastectomy. The American Society of Plastic Surgeons elucidated that breast implantation continues to be one of the top 5 cosmetic surgical procedures conducted across the world since 2006. Silicone implants were used in approximately 84% & saline implants in almost 16% of all breast augmentations performed in 2020. Moreover, an increase in the number of breast reconstruction procedures, along with technological advancements is expected to impel market growth. Thus, as a result of the increase in the number of people suffering from breast cancer, the demand for breast reconstruction is expected to increase. Furthermore, various factors such as growing research and development activities are also expected to drive the demand for the analyzers over the forecast period which is responsible for the excessive use and also significantly contributes to the market for the medical applications of breast reconstruction.

Mentor Worldwide LLC, Allergan Inc., Johnson & Johnson, SientraInc., GC Aesthetics, Ideal Implant Incorporated, POLYTECH Health & Aesthetics GmbH, CEREPLAS, AbbVie Inc., Establishment Labs S.A. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst Product Type, breast implants category accounted for the majority share in the market in 2020"

Based on product type, the market is classified into breast implants, tissue expanders, acellular dermal matrices, and others. Among these, breast implants are expected to witness the highest CAGR during the forecast period. This is mainly due to the short surgical period and deficiency of donor sites; patients generally favor implants for the breast reconstruction procedure. The rising use of breast implants during breast augmentation surgeries are widely used technology and has many benefits such as the compact size of devices and minimum power requirements. For instance, according to the NCBI, around 8.08 women per 1,000 in the U.S. has one or other kind of breast implant.

"Amongst Procedure, immediate is expected to witness highest CAGR during the forecast period"

Based on procedure, the market is classified into immediate, delayed, and revision. Amongst these, the alcohol detection category accounted for a significant share of the market. This is mainly due to its immediate reconstruction method being a better option due to its aesthetic effect, cost-effectiveness, and psychological effects and most women opt for the immediate reconstruction method. For instance, in May 2021, GC Aesthetics launched its next-generation round silicone breast implant PERLE. Over the forthcoming years, this segment rising due to the use of breast reconstruction in the global market is likely to boost the demand for breast reconstruction.

"Amongst End User, hospitals are expected to witness highest CAGR during the forecast period"

Based on end user, the market is categorized into hospitals, ambulatory surgical centers, cosmetology clinics, and others. Among these, hospitals are expected to witness the highest CAGR during the forecast period. The dominance of the segment can be attributed to a rise in the number of hospitals worldwide. Moreover, as per The Canadian Encyclopedia, there are 706 public and 193 private hospitals in Canada. Additionally, there has been an increase in medical tourism globally. An increase in medical tourism is expected to increase the quality of healthcare facilities provided by the hospitals. For instance, as per the Plastic Surgery Statistics Report, around 1,692,717 breast reconstruction surgeries were performed in ambulatory surgical centers ASCs.

"North America to witness significant growth during the forecast period"

North America is expected to show the highest CAGR growth in the breast reconstruction market. The major contributors to the growth of this market are US and Canada. This can be attributed due to the rising number of breast cancer patients coupled with high product adoption rates, and awareness about breast reconstruction in the U.S. economy in this region. According to CDC (Centers for Disease Control and Prevention), in the United States, approximately 255,000 cases of breast cancer are diagnosed in women and 2300 in men each year. Thus, the growing consumption of alcohol, increasing research on the medical applications of breast reconstruction, and the development of advanced breast reconstruction by major companies and the diagnostics industry owing to the presence of well-established market players and frequent product launches in the region.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

Global breast reconstruction market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Limitation
  • 1.3. Stakeholders
  • 1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Breast Reconstruction Market
  • 2.2. Research Methodology of the Breast Reconstruction Market
  • 2.4. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL BREAST RECONSTRUCTION MARKET COVID-19 IMPACT

6 GLOBAL BREAST RECONSTRUCTION MARKET REVENUE (USD BN), 2019-2027F

7 MARKET INSIGHTS BY PRODUCT TYPE

  • 7.1. Breast Implants
  • 7.2. Tissue Expanders
  • 7.3. Acellular Dermal Matrix (ADM)

8 MARKET INSIGHTS BY PROCEDURE

  • 8.1. Immediate
  • 8.2. Delayed
  • 8.3. Revision

9 MARKET INSIGHTS BY PLACEMENT

  • 9.1. Dual Plane Insertion
  • 9.2. Subglandular Insertion
  • 9.3. Submuscular Insertion

10 MARKET INSIGHTS BY END USER

  • 10.1. Hospitals
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Cosmetology Clinics

11 MARKET INSIGHTS BY REGION

  • 11.1. North America
    • 11.1.1. U.S.
    • 11.1.2. Canada
    • 11.1.3. Rest of North America
  • 11.2. Europe
    • 11.2.1. Germany
    • 11.2.2. UK
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3. Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Australia
    • 11.3.5. Rest of Asia-Pacific
  • 11.4. Rest of World

12 BREAST RECONSTRUCTION MARKET DYNAMICS

  • 12.1. Market Drivers
  • 12.2. Market Challenges
  • 12.3. Impact Analysis

13 BREAST RECONSTRUCTION MARKET OPPORTUNITIES

14 BREAST RECONSTRUCTION MARKET TRENDS

15 POLICY & REGULATORY FRAMEWORK

16 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 16.1. Demand Side Analysis
  • 16.2. Supply Side Analysis

17 VALUE CHAIN ANALYSIS

18 COMPETITIVE SCENARIO

  • 18.1. Competitive Landscape
    • 18.1.1. Porter's Five Forces Analysis

19 COMPANY PROFILED

  • 19.1. Mentor Worldwide LLC
  • 19.2. Allergan Inc.
  • 19.3. Johnson & Johnson
  • 19.4. SientraInc
  • 19.5. GC Aesthetics
  • 19.6. Ideal Implant Incorporated
  • 19.7. POLYTECH Health & Aesthetics GmbH
  • 19.8. CEREPLAS
  • 19.9. AbbVie Inc.
  • 19.10. Establishment Labs S.A.

20 DISCLAIMER